These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. Clemmons DR; Snyder DK; Williams R; Underwood LE J Clin Endocrinol Metab; 1987 May; 64(5):878-83. PubMed ID: 3558728 [TBL] [Abstract][Full Text] [Related]
12. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. Crist DM; Peake GT; Mackinnon LT; Sibbitt WL; Kraner JC Metabolism; 1987 Dec; 36(12):1115-7. PubMed ID: 3683183 [TBL] [Abstract][Full Text] [Related]
13. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493 [TBL] [Abstract][Full Text] [Related]
14. Persistent lipolytic effect of exogenous growth hormone during caloric restriction. Snyder DK; Underwood LE; Clemmons DR Am J Med; 1995 Feb; 98(2):129-34. PubMed ID: 7847429 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment. Clasen BF; Poulsen MM; Escande C; Pedersen SB; Møller N; Chini EN; Jessen N; Jørgensen JO J Clin Endocrinol Metab; 2014 Dec; 99(12):E2565-73. PubMed ID: 25050904 [TBL] [Abstract][Full Text] [Related]
16. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411 [TBL] [Abstract][Full Text] [Related]
17. GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. Di Somma C; Angrisani L; Rota F; Savanelli MC; Cascella T; Belfiore A; Orio F; Lombardi G; Colao A; Savastano S Clin Endocrinol (Oxf); 2008 Sep; 69(3):393-9. PubMed ID: 18194484 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone affects both adiposity and voluntary food intake in old and obese female rats. Malmlöf K; Din N; Johansen T; Pedersen SB Eur J Endocrinol; 2002 Jan; 146(1):121-8. PubMed ID: 11751077 [TBL] [Abstract][Full Text] [Related]
19. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women. Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062 [TBL] [Abstract][Full Text] [Related]
20. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Cohn L; Feller AG; Draper MW; Rudman IW; Rudman D Clin Endocrinol (Oxf); 1993 Oct; 39(4):417-25. PubMed ID: 8287568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]